enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Donepezil - Wikipedia

    en.wikipedia.org/wiki/Donepezil

    Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. [ 3 ] [ 4 ] [ 8 ] It appears to result in a small benefit in mental function and ability to function. [ 9 ]

  3. Donanemab – what we know about the latest Alzheimer’s drug

    www.aol.com/donanemab-know-latest-alzheimer-drug...

    Donanemab is a targeted antibody drug which slows down the early stages of Alzheimer’s. ... Results also suggest the drug leads to a 40% reduction in the decline of everyday activities such as ...

  4. Everything we know about breakthrough Alzheimer’s drug Donanemab

    www.aol.com/everything-know-breakthrough...

    Donanemab is a monoclonal antibody that binds to a protein that builds up in the brain during the early stages of Alzheimer’s. According to Alzheimer’s Society, the drug is a disease-modifying ...

  5. Donanemab - Wikipedia

    en.wikipedia.org/wiki/Donanemab

    Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [1] [2] Donanemab was developed by Eli Lilly and Company. [3] [4] The most common side effects include amyloid-related imaging abnormalities and headache. [2] Donanemab was approved for medical use in the United States in July 2024.

  6. 5 major Alzheimer’s discoveries scientists made in 2024 - AOL

    www.aol.com/5-major-alzheimer-discoveries...

    2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) in July. This was the third new approval since 2021.

  7. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [31] [32] Donanemab was developed by Eli Lilly and Company. [33] [34] The most common side effects include amyloid-related imaging abnormalities and headache. [32] Donanemab was approved for medical use in the United States in ...

  8. US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10

    www.aol.com/news/us-fda-panel-discuss-eli...

    Lilly's donanemab was declined accelerated approval by the FDA in January 2023, and on March 8, the agency said it would hold a meeting of its advisers to discuss the drug, further delaying its ...

  9. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    Seribantumab [40] mab: human: ERBB3 (HER3) cancer Setoxaximab [40] mab: chimeric: E. coli shiga toxin type-2: Setrusumab [26] mab: human: sclerostin (SOST) Sevirumab: human: cytomegalovirus: cytomegalovirus infection Sibrotuzumab: mab: humanized: FAP (gene) (FAP) cancer SGN-CD19A: mab: humanized: CD19: acute lymphoblastic leukemia and B-cell ...